14.85SEK-3.88%Mkt Cap: 308.86M SEKP/E: —Last update: 2026-05-13
Q-linea AB (publ) engages in the manufacturing and sale of instruments and consumables diagnose and treat infectious diseases in the United Kingdom, European Union, the Middle East, and the United States. It offers ASTar…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-54.33
PEG—
P/B1.02
P/S26.16
EV/EBITDA-0.59
EV/Revenue7.58
EPS (TTM)-9.08
EPS (Forward)-0.30
Cash Flow & Leverage
FCF Yield-29.95%
FCF Margin-783.36%
Operating CF-162.12M SEK
CapEx (TTM)7.56M SEK
Net Debt/EBITDA1.45
Net Debt-219.76M SEK
Technical
SMA 5020.80 (-28.6%)
SMA 20027.91 (-46.8%)
Beta—
S&P 52W Chg24.23%
Avg Vol (30d)16.42K
Avg Vol (10d)14.78K
Technical Indicators
RSI (14)17.5
MACD-1.8415
MACD Signal-1.5642
MACD Hist.-0.2773
BB Upper23.49 SEK
BB Middle18.50 SEK
BB Lower13.51 SEK
BB Width53.92%
ATR (14)1.251 SEK
Vol Ratio (20d)0.53x
52W Range
14.550% of range79.00
52W High79.00 SEK
52W Low14.55 SEK
Profitability
Gross Margin-15.26%
EBITDA Margin0.00%
Profit Margin-1644.31%
Oper. Margin-1354.72%
ROE-53.99%
ROA-49.36%
Revenue Growth-57.40%
Earnings Growth—
Balance Sheet
Debt/Equity0.02
Current Ratio10.48
Quick Ratio9.31
Book Value/Sh16.05 SEK
Cash/Share11.80 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:1000
Split DateJul 14, 2025
Ownership
Shares Out.18.95M
Float13.37M
Insiders13.96%
Institutions25.37%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap308.86M SEK
Enterprise Value89.49M SEK
Revenue (TTM)11.81M SEK
Gross Profit-1.69M SEK
Net Income (TTM)-182.49M SEK
Revenue/Share1.089 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees82
Last Price14.85 SEK
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0011527845